diacetyldiphenylurea-bisguanylhydrazone and Meningioma

diacetyldiphenylurea-bisguanylhydrazone has been researched along with Meningioma* in 1 studies

Other Studies

1 other study(ies) available for diacetyldiphenylurea-bisguanylhydrazone and Meningioma

ArticleYear
Chk2-mediated G2/M cell cycle arrest maintains radiation resistance in malignant meningioma cells.
    Cancer letters, 2011, Dec-26, Volume: 313, Issue:1

    In continuation to our studies on radioresistance in meningioma, here we show that radiation treatment (7Gy) induces G2/M cell cycle arrest in meningioma cells. Phosphorylation of Chk2, Cdc25c and Cdc2 were found to be key events since interference with Chk2 activation and cyclin B1/Cdc2 interaction led to permanent arrest followed by apoptosis. Irradiated cells showed recovery and formed aggressive intracranial tumors with rapid spread and morbidity. Nevertheless, knock down of uPAR with or without radiation induced permanent arrest in G2/M phase and subsequent apoptosis in vitro and in vivo. In conclusion, our data suggest that combination treatment with radiation and uPAR knock down or other inhibitors resulting in non-reversible G2/M arrest may be beneficial in the management of meningiomas.

    Topics: Animals; Apoptosis; Blotting, Western; Brain; Carbanilides; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Cycle Checkpoints; Cell Division; Cell Line, Tumor; Checkpoint Kinase 2; Cyclin B; Cyclin B1; Cyclin-Dependent Kinases; G2 Phase; Humans; Meningioma; Mice; Mice, Nude; Phosphorylation; Protein Serine-Threonine Kinases; Receptors, Urokinase Plasminogen Activator; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Tumor Burden; Xenograft Model Antitumor Assays

2011